Actin' up: RhoB in cancer and apoptosis

Nature Reviews Cancer

Volumn 1, Issue 2, 2001, Pages 162-168

  Prendergast, George C ^a,b  

^a DuPont Pharmaceuticals Company   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ANTINEOPLASTIC AGENT; ENZYME INHIBITOR; FARNESYL TRANS TRANSFERASE; GERANYLGERANYLTRANSFERASE TYPE I; GERANYLGERANYLTRANSFERASE TYPE-I; GUANOSINE TRIPHOSPHATE; PACLITAXEL; RAS PROTEIN; RHOB GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSFERASE; TUMOR PROTEIN;

ANIMAL; APOPTOSIS; ARTICLE; CELL ADHESION; CELL DIVISION; DNA DAMAGE; DRUG ANTAGONISM; DRUG EFFECT; ENZYME INDUCTION; GENETICS; HUMAN; METABOLISM; MOUSE; MULTIGENE FAMILY; NEOPLASM; PATHOLOGY; PHYSIOLOGY; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; STRESS;

ACTINS; ALKYL AND ARYL TRANSFERASES; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL ADHESION; CELL DIVISION; DNA DAMAGE; ENZYME INDUCTION; ENZYME INHIBITORS; FARNESYLTRANSTRANSFERASE; GUANOSINE TRIPHOSPHATE; HUMANS; MICE; MULTIGENE FAMILY; NEOPLASM PROTEINS; NEOPLASMS; PACLITAXEL; PROTEIN ISOPRENYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RAS PROTEINS; RHOB GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; STRESS;

EID: 0035523359     PISSN: 1474175X     EISSN: None     Source Type: Journal    
DOI: 10.1038/35101096     Document Type: Article

References (19)

1. Van Aelst, L. & D'Souza-Schorey, C. Rho GTPases and signaling networks. Genes Dev. 11, 2295-2322 (1997).
2. Ridley, A. J. Rho proteins: linking signaling with membrane trafficking. Traffic 2, 303-310 (2001).
3. Wu, W. J., Erickson, J. W., Lin, R. & Cerione, R. A. The β-subunit of the coatomer complex binds Cdc42 to mediate transformation. Nature 405, 800-804 (2000).
4. ↑o proteins. J. Cell Biol. 119, 617-627 (1992).
5. Lebowitz, P. F., Davide, J. P. & Prendergast, G. C. Evidence that farnesyltransferase inhibitors suppress Ras transformation by interfering with Rho activity. Mol. Cell. Biol. 15, 6613-6622 (1995).
6. Zalcman, G. et al. Regulation of Ras-related RhoB protein expression during the cell cycle. Oncogene 10, 1935-1945 (1995).
7. Lebowitz, P. & Prendergast, G. C. Functional interaction between RhoB and the transcription factor DB1. Cell Adhes. Comm. 4, 1-11 (1998).
8. Michaelson, D. et al. Differential localization of Rho GTPases in live cells: regulation by hypervariable regions and RhoGDI binding. J. Cell Biol. 152, 111-126 (2001).
9. Mellor, J., Flynn, P., Nobes, C. D., Hall, A. & Parker, P. J. Prk1 is targeted to endosomes by the small GTPase, RhoB. J. Biol. Chem. 273, 4811-4814 (1998).
10. Gampel, A., Parker, P. J. & Mellor, H. Regulation of epidermal growth factor receptor traffic by the small GTPase RhoB. Curr Biol. 9, 955-958 (1999).
11. Jahner, D. & Hunter, T. The ras-related gene RhoB is an immediate-early gene inducible by v-Fps, epidermal growth factor, and platelet-derived growth factor in rat fibroblasts. Mol. Cell. Biol. 11, 3682-3690 (1991).
12. Fritz, G., Kaina, B. & Aktories, K. The ras-related small GTP-binding protein RhoB is immediate-early inducible by DNA damaging treatments. J. Biol. Chem. 270, 25172-25177 (1995).
13. Engel, M. E., Datta, P. K. & Moses, H. L. RhoB is stabilized by transforming growth factor-β and antagonizes transcriptional activation. J. Biol. Chem. 273, 9921-9926 (1998).
14. Trapp, T. et al. GTPase RhoB: an early predictor of neuronal death after transient focal ischemia in mice. Mol. Cell. Neurosci. 17, 883-894 (2001).
15. Lebowitz, P., Casey, P. J., Prendergast, G. C. & Thissen, J. Farnesyltransferase inhibitors alter the prenylation and growth-stimulating function of RhoB. J. Biol. Chem. 272, 15591-15594 (1997).
16. Prendergast, G. C. et al. Critical role of Rho in cell transformation by oncogenic Ras. Oncogene 10, 2289-2296 (1995).
17. Du, W., Lebowitz, P. & Prendergast, G. C. Cell growth inhibition by farnesyltransferase inhibitors is mediated by gain of geranylgeranylated RhoB. Mol. Cell. Biol. 19, 1831-1840 (1999).
18. Du, W. & Prendergast, G. C. Geranylgeranylated RhoB mediates inhibition of human tumor cell growth by farnesyltransferase inhibitors. Cancer Res. 59, 5924-5928 (1999).
19. Chen, Z. et al. Both farnesylated and geranylgeranylated RhoB inhibit malignant transformation and suppress human tumor growth in nude mice. J. Biol. Chem. 275, 17974-17978 (2000).